Thrombosis in Children: Approach to Anatomic Risks, Thrombophilia, Prevention, and Treatment

Area of Science:

• Pediatric hematology
• Vascular medicine
• Thrombosis research

Background:

• Pediatric venous thromboembolism (VTE) incidence is increasing globally.
• Limited data exist on optimal VTE therapy, thrombophilia testing, and long-term complication management in children.
• Current risk-assessment models for pediatric VTE are limited by small sample sizes and lack of prospective validation.

Purpose of the Study:

• To review current knowledge and identify gaps in pediatric VTE management.
• To highlight the need for evidence-based guidelines for acute and chronic VTE care in children.
• To emphasize the importance of standardized classification and risk-modeling systems.

Main Methods:

• Literature review of existing studies on pediatric VTE.
• Analysis of current classification schemas for VTE.
• Evaluation of risk-assessment and risk-modeling systems in pediatric populations.

Main Results:

• Acute treatment options for pediatric VTE are primarily heparin-based, with thrombolysis reserved for specific cases.
• Chronic postthrombotic comorbidities are anticipated to rise, lacking established treatment paradigms.
• Existing risk-assessment tools for pediatric VTE require further validation and larger study cohorts.

Conclusions:

• There is a critical need for evidence-based guidelines to manage pediatric VTE, including therapy, testing, and long-term care.
• Development and prospective validation of robust risk-assessment tools are essential for improving pediatric VTE outcomes.
• Addressing the rising incidence of chronic postthrombotic comorbidities in children requires dedicated research and treatment strategies.